Eisner Mark 4
4 · FIBROGEN INC · Filed Jun 9, 2023
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Eisner Mark
Incoming Chief Medical Officer
Transactions
- Sale
Common Stock
2023-06-07$17.04/sh−2,042$34,792→ 162,862 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.